secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K
Filed at:   2026-06-22T20:35:33+00:00
Accession:  0001493152-26-029599
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Aspire Biopharma stockholders approve three warrant-related proposals at special meeting
--------------------------------------------------------------------------------

- Warrant Issuance Proposal: 1,742,683 for, 107,523 against, 4,818 withheld, 0 non-votes.
- Share Adjustment Proposal: 1,745,709 for, 103,550 against, 5,764 withheld, 0 non-votes.
- Exercise Price Adjustment Proposal: 1,739,702 for, 110,483 against, 4,839 withheld, 0 non-votes.
- All proposals related to warrants on common stock (ASBP) and warrants (ASBPW) under terms of Warrant Agreement dated March 17, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000149315226029599/0001493152-26-029599-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000149315226029599/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-029599

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer